1
|
Clinical Pharmacy Services Enhanced by Electronic Health Record (EHR) Access: An Innovation Narrative. PHARMACY 2022; 10:pharmacy10060170. [PMID: 36548326 PMCID: PMC9781377 DOI: 10.3390/pharmacy10060170] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2022] [Revised: 11/23/2022] [Accepted: 11/29/2022] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND Patient care in the community pharmacy setting is often hindered due to limited access to adequate patient health information (PHI). Various studies suggest that lack of access to PHI is a main reason for delay in pharmaceutical care, medication dispensing errors, and lacking interprofessional relationships between prescribers and pharmacists. Literature has shown that interprofessional collaboration and improved access to PHI can improve transitions of care and communication for pharmacists, but literature is sparse on implementation of electronic health record (HER) access within independent community pharmacies. METHODS This observational study follows implementation of HER access into a rural community pharmacy to enhance common clinical services carried out by pharmacy staff. Metrics include number of enhanced consultations by pharmacy staff, type of consultations provided, potential reimbursement, decreased need to follow up with other providers, potential for decreased time to treatment or refills, and aspects of EHR most utilized during search. RESULTS Two-hundred sixty three patients' profiles were assessed, with 164 (62.4%) deemed appropriate for EHR access and searching. Most interventions made were related to cardiovascular, endocrinologic, neuropsychiatric, and COVID-19 therapy medications. CONCLUSION EHR access in community pharmacy has the potential to improve both the quality and availability of clinical patient interventions through enhanced knowledge of PHI.
Collapse
|
2
|
Wooster J, Bethishou L, Gernant SA, On PC, Candelario DM, Uppala A, Mansukhani R, Shoair OA. Methods and Barriers to Communication Between Pharmacists During Transitions of Care. J Pharm Pract 2021; 36:548-558. [PMID: 34963352 DOI: 10.1177/08971900211064154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND Effective communication between pharmacists across healthcare settings is essential to facilitate transitions of care (TOC) and improve patient outcomes. OBJECTIVE To explore pharmacists' communication methods and preferences and identify barriers to communication during TOC. METHODS A survey was distributed to a convenience sample of pharmacists in California, Connecticut, Illinois, Massachusetts, New Jersey, and Texas. The survey collected information on pharmacists' demographics, practice settings, and clinical services, and their methods, preferences, and barriers to communication during TOC. RESULTS A total of 308 responses were included in the analysis. The majority of pharmacists practiced in inpatient pharmacy (39.3%) followed by outpatient community pharmacy (23.4%). About 57.8% of pharmacists reported involvement in TOC services. Among respondents, most reported electronic health record (EHR) as their primary method of communication to receive (66.2%) and send (55.5%) information to perform TOC services. Additionally, EHR was reported as the preferred method of communication to receive (75.4%) and send (75.5%) information during TOC. The primary reasons pharmacists reported not utilizing patient health information were lack of information (38.4%), incorrect information (36.7%), delay in receiving information (36.7%), and lack of time (34.5%). Barriers to providing TOC services included poor communication during handoffs (44.2%) and difficulty obtaining needed patient medical information (43.9%). CONCLUSION This study identified methods and barriers to communication between pharmacists during TOC across healthcare settings. This provides an opportunity for future research to develop interventions to improve communication between pharmacists at different practice settings.
Collapse
Affiliation(s)
- Jessica Wooster
- Fisch College of Pharmacy, 12347The University of Texas at Tyler, Tyler, TX, USA
| | | | | | - Phung C On
- School of Pharmacy, 1825MCPHS University, Boston, MA, USA
| | | | - Amulya Uppala
- Department of Pharmacy, 22414Overlook Medical Center, Summit, NJ, USA
| | - Rupal Mansukhani
- Ernest Mario School of Pharmacy, 15484Rutgers University, Piscataway, NJ, USA.,Morristown Medical Center, Morristown, NJ, USA
| | - Osama A Shoair
- Fisch College of Pharmacy, 12347The University of Texas at Tyler, Tyler, TX, USA
| |
Collapse
|
3
|
Cossette B, Ricard G, Poirier R, Gosselin S, Langlois MF, Imbeault P, Breton M, Couturier Y, Sirois C, Lessard-Beaudoin M, Rodrigue C, Teasdale J, Turcotte JP, Mallet L. Pharmacist-led transitions of care between hospitals, primary care clinics, and community pharmacies. J Am Geriatr Soc 2021; 70:766-776. [PMID: 34817853 DOI: 10.1111/jgs.17575] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2021] [Revised: 10/26/2021] [Accepted: 10/30/2021] [Indexed: 11/30/2022]
Abstract
BACKGROUND Pharmacist-led transitions of care (TOC) interventions have been described as some of the most promising interventions to reduce medication-related harm (MRH) in older adults. This study analyzed the feasibility of pharmacist-led TOC interventions between hospitals, multidisciplinary primary care clinics (PCC), and community pharmacies. METHODS Adults aged 65 years and older at risk of MRH in three regions of Quebec, Canada, with contrasting contexts of care based on university affiliation were recruited in this multicenter, single arm, and prospective intervention cohort. The hospital pharmacist developed the pharmaceutical care plan in collaboration with the hospital physician and transferred this plan with the hospitalization summary, at hospital discharge, to the PCC family physician and to the community and PCC pharmacists. A consultation with the community pharmacist was scheduled within seven days of hospital discharge and with the PCC pharmacist when appropriate. Feasibility outcomes included the time to complete the interventions and their location. RESULTS The 123 eligible patients had a mean age of 78.5 years, and 63.4% were females. The most frequent inclusion criterion was 10 medications or more, including one high-risk medication for 90 patients (73%). Recruitment in one region was stopped after three months due to unsuccessful recruitment of key PCC. The hospital pharmacist interventions took a median of 165 min. The first consultations of the PCC and community pharmacists took a median of 15 and 50 min. Among the 96 patients with a post-discharge pharmacist follow-up, 23 (24.0%) had a consultation with a PCC pharmacist, with 65.2% of the consultations conducted at the PCC. The community pharmacists conducted a consultation with 88 patients (93%), with more than 70% of consultations conducted by phone. CONCLUSION Our study showed the feasibility of pharmacist-led TOC interventions between hospitals, PCC, and community pharmacies and detailed the novel role that PCC pharmacists played in optimizing TOC interventions.
Collapse
Affiliation(s)
- Benoit Cossette
- Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Canada.,Research Centre on Aging, Integrated University Health and Social Services Centre of Estrie, Sherbrooke, Canada.,Department of Pharmacy, Integrated University Health and Social Services Centre of Estrie, Sherbrooke, Canada
| | - Geneviève Ricard
- Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Canada.,Department of Medicine, Integrated University Health and Social Services Centre of Estrie, Sherbrooke, Canada
| | - Rolande Poirier
- Department of Pharmacy, Integrated University Health and Social Services Centre of Estrie, Sherbrooke, Canada
| | - Suzanne Gosselin
- Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Canada.,Department of General Medicine, Integrated University Health and Social Services Centre of Estrie, Sherbrooke, Canada
| | - Marie-France Langlois
- Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Canada.,Department of Medicine, Integrated University Health and Social Services Centre of Estrie, Sherbrooke, Canada.,CHUS Research Centre, Integrated University Health and Social Services Centre of Estrie, Sherbrooke, Canada
| | - Philippe Imbeault
- Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Canada
| | - Mylaine Breton
- Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Canada
| | - Yves Couturier
- Faculty of Arts and Human Sciences, University of Sherbrooke, Sherbrooke, Canada
| | | | - Mélissa Lessard-Beaudoin
- Research Centre on Aging, Integrated University Health and Social Services Centre of Estrie, Sherbrooke, Canada
| | - Claudie Rodrigue
- Research Centre on Aging, Integrated University Health and Social Services Centre of Estrie, Sherbrooke, Canada
| | - Julie Teasdale
- Research Centre on Aging, Integrated University Health and Social Services Centre of Estrie, Sherbrooke, Canada
| | - Jean-Philippe Turcotte
- Research Centre on Aging, Integrated University Health and Social Services Centre of Estrie, Sherbrooke, Canada
| | - Louise Mallet
- Faculty of Pharmacy, University of Montreal, Montreal, Canada.,Department of Pharmacy, McGill University Health Centre, Montreal, Canada
| |
Collapse
|
4
|
Communication between hospitals, Family Medicine Groups and community pharmacists during transitions of care interventions. Res Social Adm Pharm 2021; 18:3290-3296. [PMID: 34607778 DOI: 10.1016/j.sapharm.2021.09.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2021] [Revised: 09/17/2021] [Accepted: 09/21/2021] [Indexed: 11/24/2022]
Abstract
BACKGROUND Pharmacist-led transitions of care (TOC) interventions have been associated with improved health outcomes. Community pharmacists' (CP) TOC communications have been described whereas limited evidence is available for hospital pharmacists (HP) and none for non-dispensing pharmacists, integrated into Family Medicine Groups (FMG). OBJECTIVE To assess information needs and perceptions about TOC communications of HP, FMG pharmacists (FMG-P) and CP and to identify optimal TOC practices and their barriers. METHODS In a cross-sectional design, a survey was distributed via email to the 70 pharmacists who participated in a multicenter, single group, longitudinal TOC intervention study for older adults at risk of medication-related harm. All pharmacists were surveyed on their TOC practices before the TOC study, as part of usual care. Pharmacists who followed TOC study patients were also surveyed on their TOC practices during the TOC study. RESULTS Survey responses were received from 35 pharmacists (50%), including 8 HP, 6 FMG-P and 21 CP. The frequency of communication between pharmacists of different settings increased significantly during the TOC study, with more than 80% of pharmacists reporting satisfaction with the quality of the information provided. At hospital discharge, in optimal TOC, the FMG-P and CP reported that the most important information to transfer was the reasons of hospitalization, patient weight and height, and the therapeutic intent of the medications. The main barriers to TOC implementation were the lack of clinical information about patients for FMG-P and CP and understaffing for HP. FMG-P and CP reported a similar high degree of interest in assuming responsibility for the new extended scope of practice activities of medication adjustments according to therapeutic targets or laboratory results and the implementation of a plan for gradual dose increases or drug tapering. CONCLUSIONS The surveyed pharmacists reported an increased frequency of communication and satisfaction with the information exchanged between the pharmacists of different settings during the TOC study compared to usual care, before the study. The pharmacists extended scope of practice offers new opportunities to optimize TOC interventions.
Collapse
|
5
|
Parry RA, Zule WA, Hurt CB, Evon DM, Rhea SK, Carpenter DM. Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study. Harm Reduct J 2021; 18:70. [PMID: 34238306 PMCID: PMC8265050 DOI: 10.1186/s12954-021-00517-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2020] [Accepted: 06/16/2021] [Indexed: 11/16/2022] Open
Abstract
BACKGROUND Pharmacists are among the most accessible healthcare providers in the United States and uniquely positioned to provide harm reduction services. The availability of pharmacy-based harm reduction services and pharmacist attitudes toward delivering these services have been understudied to date. We examine North Carolina (NC) pharmacists' experiences with and attitudes about harm reduction services and explore differences between rural and urban pharmacists. METHODS A convenience sample of NC pharmacists participated in an anonymous, online survey regarding harm reduction services: non-prescription syringe sales; naloxone dispensing; and human immunodeficiency virus (HIV) and hepatitis C virus (HCV) screening. Urban-rural differences were analyzed using Pearson's chi-square or Fisher's exact tests. Open-ended responses were analyzed thematically. RESULTS Three hundred pharmacists responded to the survey; 68 (23%) practiced in rural counties. Dispensing non-prescription syringes and naloxone at least occasionally was reported by 77% (n = 231) and 88% (n = 263) pharmacists, respectively. Pharmacy-delivered HIV or HCV screening was rare. Urban pharmacists dispensed naloxone more frequently than rural pharmacies (p = 0.04). Only 52% of pharmacists agreed that persons who inject drugs should always be allowed to buy non-prescription syringes. Rural pharmacists' attitudes toward harm reduction services for persons who inject drugs were statistically, though marginally, less supportive when compared to urban pharmacists' attitudes. The most common barrier to non-prescription syringe access was requiring patients to provide proof of prescription injection medication use, which 21% of pharmacists reported was required by their pharmacy's policy on non-prescription syringe sales. CONCLUSIONS Although most pharmacies distributed naloxone and sold non-prescription syringes, pharmacy store policies and personal beliefs inhibited naloxone and non-prescription syringe dispensing. NC community pharmacies infrequently offer HIV and HCV screening. Paired with disseminating the evidence of the positive impact of harm reduction on individual and public health outcomes to NC pharmacists, institutional and systems changes to practice and policy may be important to promote harm reduction service availability, particularly for rural NC residents. TRIAL REGISTRATION N/A.
Collapse
Affiliation(s)
- Rachel A Parry
- UNC Eshelman School of Pharmacy, 201 Pharmacy Lane, CB 7355, Chapel Hill, NC, 27599-7355, USA.
| | - William A Zule
- RTI International, 3040 East Cornwallis Rd., PO Box 12194, Research Triangle Park, NC, 27709-2194, USA
| | - Christopher B Hurt
- Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, 130 Mason Farm Rd, CB#7030, Chapel Hill, NC, 27599-7030, USA
| | - Donna M Evon
- Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Sarah K Rhea
- RTI International, 3040 East Cornwallis Rd., PO Box 12194, Research Triangle Park, NC, 27709-2194, USA
| | - Delesha M Carpenter
- UNC Eshelman School of Pharmacy, 201 Pharmacy Lane, CB 7355, Chapel Hill, NC, 27599-7355, USA
| |
Collapse
|
6
|
Pharmacist-led transitions of care for older adults at risk of drug-related problems: A feasibility study. Res Social Adm Pharm 2021; 17:1276-1281. [DOI: 10.1016/j.sapharm.2020.09.013] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2020] [Revised: 09/03/2020] [Accepted: 09/20/2020] [Indexed: 02/04/2023]
|
7
|
Kelsh S, de Voest M, Stout M. Improving 30-day readmissions: Student pharmacists' role in transitions of care. J Am Pharm Assoc (2003) 2021; 61:e233-e236. [PMID: 33812782 DOI: 10.1016/j.japh.2021.03.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2020] [Revised: 02/22/2021] [Accepted: 03/14/2021] [Indexed: 11/25/2022]
Abstract
BACKGROUND Pharmacists have reduced 30-day hospital readmissions when involved with transitions of care (TOC). The impact of student pharmacists on readmissions is more limited. OBJECTIVE The goal of this study was to describe student pharmacists' role in a new TOC service and determine their impact on 30-day hospital readmissions. METHODS We designed a 3-step TOC service spanning inpatient, discharge, and follow-up led by student pharmacists and involving both inpatient and ambulatory care pharmacy preceptors. The student pharmacists followed inpatient care and discussed medications with the patients. Discharge orders were reviewed, and the student pharmacists provided discharge education. On discharge, the student pharmacists wrote a handoff to the ambulatory care pharmacist describing inpatient care, discharge medication list, follow-up, and unresolved medication issues. Finally, the student pharmacists participated in the outpatient follow-up at the primary care provider office with the provider and an ambulatory care pharmacist. Readmissions were compared between this process and a standard-of-care historical control group using chi-square analysis. RESULTS The student pharmacist-led TOC service reduced 30-day hospital readmissions by 13.1% (P = 0.018) compared with standard of care. CONCLUSION Student pharmacists are effective members of the health care team in reducing readmissions. Student pharmacists are cost-effective, appropriately trained, and well positioned to assist with these services.
Collapse
|